AFC-TAB-104

antibody from Creative Biolabs
Targeting: CD2 SRBC
Provider product page for AFC-TAB-104
ELISA
Immunocytochemistry
Immunoprecipitation
Flow cytometry
Blocking/Neutralizing
Functional assay

Antibody data

Product number
AFC-TAB-104 - Provider product page
Provider
Creative Biolabs
Product name
Afuco? Anti-CD2 ADCC Recombinant Antibody (Siplizumab), ADCC Enhanced
Antibody type
Monoclonal
Description
This product is an ADCC enhanced antibody produced by our Afuco? platform. Recombinant monoclonal antibody to CD2. Siplizumab (MEDI-507) is a novel monoclonal antibody with a human IgG1, kappa directed to CD2. The agent has shown potent immunomodulatory effects, selectively suppressing the function of T and NK cells, and is currently being tested as a possible treatment for psoriasis and in the prevention of graft-versus-host disease.
Reactivity
Human
Host
Human
Conjugate
Unconjugated
Isotype
IgG
Antibody clone number
Siplizumab
Storage
Store at +4¡ãC short term (1-2 weeks). Aliquot and store at -20¡ãC long term. Avoid repeated freeze/thaw cycles.
CD2 protein structure - AFC-TAB-104 shown in red.